CYTOTOXIC T LYMPHOCYTES IN INFLUENZA VIRUS EVOLUTION
流感病毒进化中的细胞毒性 T 淋巴细胞
基本信息
- 批准号:3454119
- 负责人:
- 金额:$ 8.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-03-01 至 1993-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The long-term objective of this study is to understand the role of
cytotoxic T lymphocytes in the evolution of new human influenza A
viruses and in protection against influenza virus infection. To
accomplish this, a panel of murine cytotoxic T lymphocyte (CTL)
clones specific for the hemagglutinin (HA) of an H3 human influenza
A virus will be prepared. These clones will be analyzed in
cytotoxicity assays for their ability (or inability) to recognize
laboratory-selected and naturally-occurring variants with known HA
sequences, tested for their capacity to select variants in vivo and
in vitro, analyzed for the effect of class I MHC products on their
specificity, and examine for their ability to reduce virus
replication and mortality in mice infected with influenza viruses.
These data will be used to: (1) determine the CTL recognition
sites on the HA molecule: (2) evaluate the role of CTL in antigenic
variation (drift and shift) in influenza viruses and the role of
MHC restriction on the generation and specificity of HA-specific
CTL; and (3) establish whether HA-specific CTL protect against
morbidity and mortality in infected animals. Influenza A viruses
produce major disease problems throughout the world and the role
of CTL in the evolution of new epidemic strains has not been
defined. A better understanding of this aspect of immunity may
contribute to the future prevention of influenza and such
information also has broader implications, vis-a-vis, the overall
role of T cells in host defense.
本研究的长期目标是了解
细胞毒性T淋巴细胞在新型人A型流感病毒演变中的作用
病毒和保护免受流感病毒感染。 到
为了实现这一点,一组鼠细胞毒性T淋巴细胞(CTL)
对H3人流感的血凝素(HA)具有特异性的克隆
将准备一种病毒。 这些克隆将在
细胞毒性测定其识别(或不识别)
具有已知HA的实验室选择的和天然存在的变体
序列,测试它们在体内选择变体的能力,
在体外,分析I类MHC产物对它们的作用。
特异性,并检查它们减少病毒能力
感染流感病毒的小鼠的复制和死亡率。
这些数据将用于:(1)确定CTL识别
HA分子上的位点:(2)评估CTL在抗原性中的作用。
流感病毒的变异(漂移和转移)以及
MHC对HA特异性抗原的产生和特异性的限制
CTL;和(3)确定HA特异性CTL是否保护免于
感染动物的发病率和死亡率。 甲型流感病毒
在世界范围内产生重大疾病问题,
CTL在新流行毒株进化中的作用尚未得到证实。
定义了 更好地理解免疫的这一方面,
有助于今后预防流感等
信息也有更广泛的影响,相对于,
T细胞在宿主防御中的作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIRGINIA S HINSHAW其他文献
VIRGINIA S HINSHAW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIRGINIA S HINSHAW', 18)}}的其他基金
IMMUNOLOGY & PATHOGENESIS OF INFLUENZA VIRUSES W/ HIGH RESOLUTION CRYO SEM
免疫学
- 批准号:
6117273 - 财政年份:1998
- 资助金额:
$ 8.14万 - 项目类别:
IMMUNOLOGY & PATHOGENESIS OF INFLUENZA VIRUSES W/ HIGH RESOLUTION CRYO SEM
免疫学
- 批准号:
6278468 - 财政年份:1998
- 资助金额:
$ 8.14万 - 项目类别:
IMMUNE RECOGNITION & PATHOGENESIS OF INFLUENZA VIRUSES: HIGH RESOLUTION CRYO SEM
免疫识别
- 批准号:
6248573 - 财政年份:1997
- 资助金额:
$ 8.14万 - 项目类别:
APOPTOSIS--MECHANISM OF CELL KILLING BY INFLUENZA VIRUS
细胞凋亡--流感病毒杀伤细胞的机制
- 批准号:
2068964 - 财政年份:1994
- 资助金额:
$ 8.14万 - 项目类别:
APOPTOSIS--MECHANISM OF CELL KILLING BY INFLUENZA VIRUS
细胞凋亡--流感病毒杀伤细胞的机制
- 批准号:
2068962 - 财政年份:1994
- 资助金额:
$ 8.14万 - 项目类别:
APOPTOSIS--MECHANISM OF CELL KILLING BY INFLUENZA VIRUS
细胞凋亡--流感病毒杀伤细胞的机制
- 批准号:
2068965 - 财政年份:1994
- 资助金额:
$ 8.14万 - 项目类别:
CYTOTOXIC T LYMPHOCYTES IN INFLUENZA VIRUS EVOLUTION
流感病毒进化中的细胞毒性 T 淋巴细胞
- 批准号:
3454121 - 财政年份:1988
- 资助金额:
$ 8.14万 - 项目类别:
相似海外基金
Immunoregulation of cellular immunity and tissue homeostasis during Chagas' disease
恰加斯病期间细胞免疫和组织稳态的免疫调节
- 批准号:
10448950 - 财政年份:2022
- 资助金额:
$ 8.14万 - 项目类别:
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
编码免疫受体靶向抗体的 mRNA,用于增强疫苗引发的细胞免疫。
- 批准号:
10508093 - 财政年份:2022
- 资助金额:
$ 8.14万 - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10501418 - 财政年份:2022
- 资助金额:
$ 8.14万 - 项目类别:
Gingival vaccination strategy to induce both humoral and cellular immunity ideal for elderly vaccination
诱导体液和细胞免疫的牙龈疫苗接种策略非常适合老年人疫苗接种
- 批准号:
22K09932 - 财政年份:2022
- 资助金额:
$ 8.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SHINING A LIGHT ON BAT CELLULAR IMMUNITY FOLLOWING VIRUS INFECTION
揭示病毒感染后蝙蝠细胞免疫
- 批准号:
10449406 - 财政年份:2022
- 资助金额:
$ 8.14万 - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10650823 - 财政年份:2022
- 资助金额:
$ 8.14万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10568736 - 财政年份:2022
- 资助金额:
$ 8.14万 - 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
- 批准号:
10797812 - 财政年份:2022
- 资助金额:
$ 8.14万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10895221 - 财政年份:2022
- 资助金额:
$ 8.14万 - 项目类别:
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
编码免疫受体靶向抗体的 mRNA,用于增强疫苗引发的细胞免疫。
- 批准号:
10662571 - 财政年份:2022
- 资助金额:
$ 8.14万 - 项目类别:














{{item.name}}会员




